News (30)

Fresenius : Meeting Participation by individual Supervisory Board member 2023 PU
Fresenius Medical Care : simplifies corporate structure by converting into a German stock corporation - Form 6-K PU
Fresenius Medical Care : simplifies corporate structure by converting into a German stock corporation PU
Transcript : Fresenius Medical Care AG & Co. KGaA - Shareholder/Analyst Call
Fresenius Medical Care : proposes candidates for election to the new Supervisory Board after conversion PU
Transcript : Fresenius Medical Care AG & Co. KGaA - Shareholder/Analyst Call
Ralf W. Dieter, former CEO of Dürr AG, to become new member of TeamViewer’s Supervisory Board EQ
Transcript : Fresenius Medical Care AG & Co. KGaA - Shareholder/Analyst Call
Transcript : WW International, Inc., Q1 2022 Earnings Call, May 05, 2022
Fresenius SE & Co. KGaA: Announcement of the Convening of the General Meeting on May 13, 2022 according to article 121 AktG (German Stock Companies Act) with the objective of Europe-wide distribution EQ
Fresenius Medical Care : Invitation to the Annual General Meeting - Form 6-K PU
Volkswagen : Christian Schenk will become the new Board Member for Finance and IT at ŠKODA AUTO on 1 October 2021, succeeding Klaus-Dieter Schürmann, who has been responsible for the department for five years. ... PU
Fresenius Medical Care: 2025 growth targets confirmed, Annual General Meeting approves 24th consecutive dividend increase PU
Transcript : Fresenius Medical Care AG & Co. KGaA - Shareholder/Analyst Call
TubeSolar AG: TubeSolar launches far-reaching cooperation with green roof system manufacturer ZinCo EQ
Fresenius Medical Care : Declaration on Corporate Governance PU
Fresenius Medical Care : Report by the Supervisory Board PU
Transcript : Fresenius Medical Care AG & Co. KGaA - Shareholder/Analyst Call
Transcript : Dürr Aktiengesellschaft, Q1 2020 Earnings Call, May 14, 2020
Technotrans SE: Personnel changes on the Board of Management and Supervisory Board of technotrans SE EQ
Fresenius SE & Co. KGaA : Notification and public disclosure of transactions by persons EQ
TUI AG: Annual Financial Report - Part 2 EQ
Fresenius Medical Care : Professor Dr. Gregor Zünd appointed for the Supervisory Board of Fresenius Medical Care PU
Fresenius Medical Care AG & Co. KGaA: Professor Dr. Gregor Zünd appointed for the Supervisory Board of Fresenius Medical Care EQ
Fresenius Medical Care : forecasts continued strong growth - Annual General Meeting approves 21st straight dividend increase EQ
Fresenius Medical Care AG & Co. KGaA Approves Dividend; Announces Board Changes CI
Fresenius Medical Care : forecasts continued strong growth – Annual General Meeting approves 21st straight dividend increase PU
Greiffenberger : Press Release, October 25, 2016 PU
Greiffenberger : Press Release, August 25, 2016 PU
Fresenius SE KGaA : nominates Supervisory Board candidates for election by 2016 Annual General Meeting PU

Companies (1)

ISOENERGY LTD. 532 M $
Logo IsoEnergy Ltd.

IsoEnergy Ltd. is a Canada-based diversified uranium company. The Company is engaged in the acquisition, exploration, and evaluation of uranium properties in Canada, the United States of America, Australia, and Argentina. The Company is focused on advanci ...


Insiders

Picture Dieter Schenk
Dieter Schenk

Dieter Schenk is a businessperson who has been the head of 6 different companies and currently holds the position of Chairman-Supervisory Board of Fresenius Medical Care AG & Co. KGaA, Chairman-Supervisory Board at Gabor Shoes AG, Chairman-Supervisory Board of TOPTICA Photonics AG and Chairman for HWT Invest AG. Dr. Schenk is also on the board of Fresenius Medical Care Management AG and Fresenius Management SE and Chairman at Else Kröner-Fresenius-Stiftung. In his past career Dr. Schenk was Chairman-Supervisory Board of Bank Schilling & Co. AG and Partner at Noerr LLP. Dieter Schenk received a doctorate from Ludwig-Maximilians-Universität München.



Picture Dieter Schenke
Dieter Schenke

Dieter Schenke currently works as a Co-Managing Director at Hans Witteler GmbH & Co. KG.





Picture Dale B. Schenk
Dale B. Schenk

Dale B.
Schenk
worked as the Chief Scientific Officer & EVP at Elan Corp.
Plc from 1999 to 2012.
Prior to that, he was the Neurobiology Director at Athena Neurosciences LLC from 1987 to 1998.
From 2012 to 2016, he served as the President, Chief Executive Officer & Director at Prothena Corp.
Plc.
Schenk received his undergraduate and doctorate degrees from the University of California San Diego.




Picture Hermann Schenk
Hermann Schenk

Hermann Schenk has a current job as a trustee at the Fraunhofer Institute for Photonic Microsystems.

No results for this search